Comparison of Intermittent and Continuous Androgen Deprivation Therapy in Prostate Cancer Patients: An Up-to-Date Meta-analysis for Urologists and Medical Providers.

Author: BeckerBenjamin, ReddyAnish, StroeverStephanie, de RieseWerner T W

Paper Details 
Original Abstract of the Article :
Androgen deprivation therapy first became the treatment of choice for advanced prostate cancer in the 1940s with Charles Huggins' discoveries. Eight decades later, androgen deprivation therapy has significantly evolved, and yet is still utilized in various ways to treat certain forms of prostate can...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1097/UPJ.0000000000000424

データ提供:米国国立医学図書館(NLM)

Androgen Deprivation Therapy: A New Frontier in Prostate Cancer Treatment

This research delves into the world of prostate cancer treatment, exploring the effectiveness of androgen deprivation therapy (ADT). This treatment, which has been around for decades, has evolved significantly since its inception. The authors conducted a meta-analysis to evaluate the effects of continuous and intermittent ADT on mortality rates in patients with prostate cancer. They focused on understanding the impact of ADT on prostate cancer-specific mortality and non-prostate cancer causes.

While continuous ADT has historically been the standard treatment, intermittent ADT has emerged as an alternative approach. This study provides an updated review of the evidence surrounding the efficacy of both approaches. The authors aimed to offer guidance to healthcare providers in choosing the appropriate form of ADT for their patients.

The Right Treatment for You

The study suggests that both continuous and intermittent ADT have their own benefits and drawbacks. The best treatment option for each patient will depend on individual factors such as the stage and severity of the cancer, potential side effects, and patient preferences.

Living with Prostate Cancer

Prostate cancer is a challenging diagnosis. This research highlights the advancements in treatment options available to patients. If you or someone you know is affected by prostate cancer, it's important to consult with a healthcare professional to develop a personalized treatment plan.

Dr. Camel's Conclusion

The study underscores the complexity of prostate cancer treatment. The evolution of ADT offers a diverse range of options for patients. Just as the desert is full of diverse landscapes, the world of prostate cancer treatment is continually changing. Stay informed, seek expert advice, and navigate this journey with hope.

Date :
  1. Date Completed 2023-08-21
  2. Date Revised 2023-09-08
Further Info :

Pubmed ID

37505912

DOI: Digital Object Identifier

10.1097/UPJ.0000000000000424

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.